Delivery Order SPE2DB20D3103-SPE2DB23FL9J1
- Not listed
- This federal contract award, valued at $1,669.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 1,200,000 units of 2ml Bicillin L-A, a pharmaceutical product. This is a firm fixed-price delivery order contract with an ultimate completion date of January 31, 2024. The contract does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $8,226.75 for the supply of 1,200,000 units of Bicillin L-A, a pharmaceutical product. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of February 13, 2024. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating it was awarded through full and open competition....
- This federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of 1,200,000 units of Bicillin L-A, a prescription medication, with an ultimate completion date of December 27, 2023. The contract has a ceiling value of $3,217.62 and is structured as a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $1,072.54 for the supply of 1,200,000 units of Bicillin L-A 2ml. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of July 7, 2023. The contract is a Firm Fixed Price arrangement and is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,992.38 for the supply of 2,400,000 units of Bicillin L-A, a 4 ml injectable medication. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of September 28, 2022. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., provides 1,200,000 units of Bicillin L-A, a prescription medication, for a ceiling value of $1,072.54. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,154.02 for the supply of 1,200,000 units of Bicillin L-A, a pharmaceutical product. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which...
- This federal contract award, valued at $53,904.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 1,200,000 units of Bicillin L-A, a medication, to support military healthcare programs. The contract is a Firm Fixed Price Delivery Order with a completion date of May 24, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which holds a significant $999,999,999 Indefinite...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $53,627.00 for the supply of Bicillin L-A, a penicillin-based medication, to the Defense Logistics Agency (DLA). The contract has an ultimate completion date of August 29, 2023 and was awarded on August 28, 2023. This is a firm fixed-price contract, and there is no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order (SPE2DB22FL39E) valued at $161,714.88 for the supply of 1,200,000 units of Bicillin L-A, a pharmaceutical product. The award was made by the Defense Logistics Agency (DLA), a defense agency, on May 16, 2022, with a completion date of May 17, 2022. This contract does not have a set-aside designation, indicating it was competed openly. Amerisourcebergen Drug Corp holds a significant...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FL9J1Delivery Order
This federal contract award, valued at $53,904.96, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 1,200,000 units of Bicillin L-A, a pharmaceutical product, with a completion date of December 19, 2022. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense and Department of Veterans Affairs healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $53.9k | 12/16/22 |